Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity

Seminars in Cell and Developmental Biology

Volumn 72, Issue , 2017, Pages 101-116

  Seilie, E Sachiko ^a   Bubeck Wardenburg, Juliane ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Alpha toxin; Hemolysin; Leukocidin; Pore forming toxins; S. aureus vaccines and therapeutics; Staphylococcus aureus

Indexed keywords

ADAM10 ENDOPEPTIDASE; BACTERIAL TOXIN; BETA CYCLODEXTRIN DERIVATIVE; CAVEOLIN; CD11B ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; PANTON VALENTINE LEUKOCIDIN; BACTERIAL PROTEIN; LEUKOCIDIN;

APOPTOSIS; BACTERIAL SURVIVAL; BONE MARROW CELL; DISEASE SEVERITY; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PATHOGENESIS; QUORUM SENSING; REGULATORY MECHANISM; REVIEW; STAPHYLOCOCCUS AUREUS; ANIMAL; BIOLOGICAL MODEL; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; HOST-PATHOGEN INTERACTIONS; HUMANS; LEUKOCIDINS; MODELS, BIOLOGICAL; RECEPTORS, CELL SURFACE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 85018405739     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2017.04.003     Document Type: Review

References (209)

1. Alouf, J.E., Molecular features of the cytolytic pore-forming bacterial protein toxins. Folia Microbiol. (Praha) 48:1 (2003), 5–16.
2. Bischofberger, M., Iacovache, I., van der Goot, F.G., Pathogenic pore-forming proteins: function and host response. Cell Host Microbe 12:3 (2012), 266–275.
3. Dal Peraro, M., van der Goot, F.G., Pore-forming toxins: ancient, but never really out of fashion. Nat. Rev. Microbiol. 14:2 (2016), 77–92.
4. Berube, B., Wardenburg, J., Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins 5:6 (2013), 1140–1166.
5. Rasigade, J.P., Vandenesch, F., Staphylococcus aureus: a pathogen with still unresolved issues. Infect. Genet. Evol. 21 (2014), 510–514.
6. Tong, S.Y., Davis, J.S., Eichenberger, E., Holland, T.L., Fowler, V.G. Jr., Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 28:3 (2015), 603–661.
7. Alonzo, F. 3rd, Torres, V.J., The bicomponent pore-forming leucocidins of Staphylococcus aureus. Microbiol. Mol. Biol. Rev. 78:2 (2014), 199–230.
8. Inoshima, I., Inoshima, N., Wilke, G.A., Powers, M.E., Frank, K.M., Wang, Y., Bubeck Wardenburg, J., A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat. Med. 17:10 (2011), 1310–1314.
9. Dumont, A.L., Nygaard, T.K., Watkins, R.L., Smith, A., Kozhaya, L., Kreiswirth, B.N., Shopsin, B., Unutmaz, D., Voyich, J.M., Torres, V.J., Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol. Microbiol. 79:3 (2011), 814–825.
10. Alonzo, F. 3rd, Benson, M.A., Chen, J., Novick, R.P., Shopsin, B., Torres, V.J., Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol. Microbiol. 83:2 (2012), 423–435.
11. Vrieling, M., Koymans, K.J., Heesterbeek, D.A., Aerts, P.C., Rutten, V.P., de Haas, C.J., van Kessel, K.P., Koets, A.P., Nijland, R., van Strijp, J.A., Bovine Staphylococcus aureus secretes the leukocidin LukMF’ to kill migrating neutrophils through CCR1. MBio, 6(3), 2015, e00335.
12. Diep, B.A., Palazzolo-Ballance, A.M., Tattevin, P., Basuino, L., Braughton, K.R., Whitney, A.R., Chen, L., Kreiswirth, B.N., Otto, M., DeLeo, F.R., Chambers, H.F., Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS One, 3(9), 2008, e3198.
13. Lipinska, U., Hermans, K., Meulemans, L., Dumitrescu, O., Badiou, C., Duchateau, L., Haesebrouck, F., Etienne, J., Lina, G., Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS One, 6(8), 2011, e22864.
14. Spaan, A.N., Vrieling, M., Wallet, P., Badiou, C., Reyes-Robles, T., Ohneck, E.A., Benito, Y., de Haas, C.J., Day, C.J., Jennings, M.P., Lina, G., Vandenesch, F., van Kessel, K.P., Torres, V.J., van Strijp, J.A., Henry, T., The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors. Nat. Commun., 5, 2014, 5438.
15. Spaan, A.N., Reyes-Robles, T., Badiou, C., Cochet, S., Boguslawski, K.M., Yoong, P., Day, C.J., de Haas, C.J., van Kessel, K.P., Vandenesch, F., Jennings, M.P., Le Van Kim, C., Colin, Y., van Strijp, J.A., Henry, T., Torres, V.J., Staphylococcus aureus targets the Duffy antigen receptor for chemokines (DARC) to lyse erythrocytes. Cell Host Microbe 18:3 (2015), 363–370.
16. Burnet, F.M., The exotoxins of Staphylococcus pyogenes aureus. J. Pathol. Bacteriol. 32 (1929), 717–734.
17. Bhakdi, S., Tranum-Jensen, J., Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55:4 (1991), 733–751.
18. Glenny, A.T., Stevens, M.F., Staphylococcal toxins and antitoxins. J. Pathol. Bacteriol. 90:2 (1935), 201–210.
19. Song, L., Hobaugh, M.R., Shustak, C., Cheley, S., Bayley, H., Gouaux, J.E., Structure of staphylococcal α-hemolysin, a heptameric transmembrane pore. Science 274:5294 (1996), 1859–1865.
20. Gouaux, J.E.O., Braha, M.R., Hobaugh, L., Song, S., Cheley, C., Shustak Bayley, H., Subunit stoichiometry of staphylococcal α-hemolysin in crystals and on membranes: a heptameric transmembrane pore. Proc. Natl. Acad. Sci. U. S. A. 91:26 (1994), 12828–12831.
21. Montgomery, C.P., Boyle-Vavra, S., Adem, P.V., Lee, J.C., Husain, A.N., Clasen, J., Daum, R.S., Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J. Infect. Dis. 198:4 (2008), 561–570.
22. DeLeo, F.R., Kennedy, A.D., Chen, L., Bubeck Wardenburg, J., Kobayashi, S.D., Mathema, B., Braughton, K.R., Whitney, A.R., Villaruz, A.E., Martens, C.A., Porcella, S.F., McGavin, M.J., Otto, M., Musser, J.M., Kreiswirth, B.N., Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 108:44 (2011), 18091–18096.
23. Bubeck Wardenburg, J.T., Bae, M., Otto, F.R., Deleo Schneewind, O., Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13:12 (2007), 1405–1406.
24. Tavares, A., Nielsen, J.B., Boye, K., Rohde, S., Paulo, A.C., Westh, H., Schonning, K., de Lencastre, H., Miragaia, M., Insights into alpha-hemolysin (Hla) evolution and expression among Staphylococcus aureus clones with hospital and community origin. PLoS One, 9(7), 2014, e98634.
25. Novick, R.P., Projan, S.J., Kornblum, J., Ross, H.F., Ji, G., Kreiswirth, B., Vandenesch, F., Moghazeh, S., The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol. Gen. Genet. 248:4 (1995), 446–458.
26. Novick, R.P., Ross, H.F., Projan, S.J., Kornblum, J., Kreiswirth, B.N., Moghazeh, S., Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12:10 (1993), 3967–3975.
27. Cheung, A.L., Koomey, J.M., Butler, C.A., Projan, S.J., Fischetti, V.A., Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc. Natl. Acad. Sci. U. S. A. 89:14 (1992), 6462–6466.
28. Chien, Y., Manna, A., Cheung, A.L., SarA level is a determinant of agr activation in Staphylococcus aureus. Mol. Microbiol. 30:5 (1998), 991–1001.
29. Giraudo, A.T., Cheung, A.L., Nagel, R., The sae locus of Staphylococcus aureus controls exoprotein synthesis at the transcriptional level. Arch. Microbiol. 168 (1997), 53–58.
30. Novick, R.P., Jiang, D., The staphylococcal saeRS system coordinates environmental signals with agr quorum sensing. Microbiology 149:Pt. 10 (2003), 2709–2717.
31. Montgomery, C.P., Boyle-Vavra, S., Daum, R.S., Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS One, 5(12), 2010, e15177.
32. Powers, M.E., Kim, H.K., Wang, Y., Bubeck Wardenburg, J., ADAM10 mediates vascular injury induced by Staphylococcus aureus α-hemolysin. J. Infect. Dis. 206:3 (2012), 352–356.
33. Patel, A.H., Nowlan, P., Weavers, E.D., Foster, T., Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect. Immun. 55:12 (1987), 3103–3110.
34. Tkaczyk, C., Hamilton, M.M., Datta, V., Yang, X.P., Hilliard, J.J., Stephens, G.L., Sadowska, A., Hua, L., O'Day, T., Suzich, J., Stover, C.K., Sellman, B.R., Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis model. PLoS One, 8(10), 2013, e75103.
35. Inoshima, N., Wang, Y., Bubeck Wardenburg, J., Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection. J. Invest. Dermatol. 132:5 (2012), 1513–1516.
36. Bramley, A.J., Patel, A.H., O'Reilly, M., Foster, R., Foster, T.J., Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect. Immun. 57:8 (1989), 2489–2494.
37. O'Callaghan, R.J., Callegan, M.C., Moreau, J.M., Green, L.C., Foster, T.J., Hartford, O.M., Engel, L.S., Hill, J.M., Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect. Immun. 65:5 (1997), 1571–1578.
38. McElroy, M.C., Harty, H.R., Hosford, G.E., Boylan, G.M., Pittet, J.F., Foster, T.J., Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect. Immun. 67:10 (1999), 5541–5544.
39. Bubeck Wardenburg, J., Patel, R.J., Schneewind, O., Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun. 75:2 (2007), 1040–1044.
40. van de Velde, H., Étude sur le mecanisme de la virulence du Staphylocoque pyogene. Cellule 10 (1894), 401–410.
41. Julianelle, L.A., Studies of hemolytic staphylococci: hemolyticactivity— biochemical reactions—serologic reactions. J. Infect. Dis. 31 (1922), 256–284.
42. Panton, P.N., Valentine, F.C.O., Staphylococcal toxin. Lancet 1:5662 (1932), 506–508.
43. Alonzo, F. 3rd, Torres, V.J., Bacterial survival amidst an immune onslaught: the contribution of the Staphylococcus aureus leukotoxins. PLoS Pathog., 9(2), 2013, e1003143.
44. Reyes-Robles, T., Alonzo, F. 3rd, Kozhaya, L., Lacy, D.B., Unutmaz, D., Torres, V.J., Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. Cell Host Microbe 14:4 (2013), 453–459.
45. DuMont, A.L., Yoong, P., Day, C.J., Alonzo, F. 3rd, McDonald, W.H., Jennings, M.P., Torres, V.J., Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1. Proc. Natl. Acad. Sci. U. S. A. 110:26 (2013), 10794–10799.
46. Cooney, J.Z., Kienle, T.J., Foster O'Toole, P.W., The gamma-hemolysin locus of Staphylococcus aureus comprises three linked genes, two of which are identical to the genes for the F and S components of leukocidin. Infect. Immun. 61:2 (1993), 768–771.
47. Woodin, A.M., Fractionation of a leucocidin from Staphylococcus aureus. Biochem. J. 73:225–237 (1959), 225–237.
48. Sugawara, N., Tomita, T., Sato, T., Kamio, Y., Assembly of Staphylococcus aureus leukocidin into a pore-forming ring-shaped oligomer on human polymorphonuclear leukocytes and rabbit erythrocytes. Biosci. Biotechnol. Biochem. 63:5 (1999), 884–891.
49. Olson, R., Nariya, H., Yokota, K., Kamio, Y., Gouaux, E., Crystal structure of staphylococcal LukF delineates conformational changes accompanying formation of a transmembrane channel. Nat. Struct. Biol. 6:2 (1999), 134–140.
50. Sugawara-Tomita, N.T., Tomita Kamio, Y., Stochastic assembly of two-component staphylococcal γ-hemolysin into heteroheptameric transmembrane pores with alternate subunit arrangements in ratios of 3:4 and 4:3. J. Bacteriol. 184:17 (2002), 4747–4756.
51. Miles, G., Movileanu, L., Bayley, H., Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore. Protein Sci. 11:4 (2002), 894–902.
52. Joubert, O., Viero, G., Keller, D., Martinez, E., Colin, D.A., Monteil, H., Mourey, L., Dalla Serra, M., Prevost, G., Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions. Biochem. J. 396:2 (2006), 381–389.
53. Spaan, A.N., Schiepers, A., de Haas, C.J., van Hooijdonk, D.D., Badiou, C., Contamin, H., Vandenesch, F., Lina, G., Gerard, N.P., Gerard, C., van Kessel, K.P., Henry, T., van Strijp, J.A., Differential interaction of the staphylococcal toxins Panton-Valentine leukocidin and gamma-Hemolysin CB with human C5a receptors. J. Immunol. 195:3 (2015), 1034–1043.
54. Kaneko, J.T., Ozawa, T., Tomita Kamio, Y., Sequential binding of Staphylococcal γ-hemolysin to human erythrocytes and complex formation of the hemolysin on the cell surface. Biosci. Biotechnol. Biochem. 61:5 (1997), 846–851.
55. DuMont, A.L., Yoong, P., Liu, X., Day, C.J., Chumbler, N.M., James, D.B., Alonzo, F. 3rd, Bode, N.J., Lacy, D.B., Jennings, M.P., Torres, V.J., Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition. Infect. Immun. 82:3 (2014), 1268–1276.
56. Ventura, C.L., Malachowa, N., Hammer, C.H., Nardone, G.A., Robinson, M.A., Kobayashi, S.D., DeLeo, F.R., Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS One, 5(7), 2010, e11634.
57. Kaneko, J., Kimura, T., Kawakami, Y., Tomita, T., Kamio, Y., Panton-valentine leukocidin genes in a phage-like particle isolated from mitomycin C-treated Staphylococcus aureus V8 (ATCC 49775). Biosci. Biotechnol. Biochem. 61:11 (1997), 1960–1962.
58. Kaneko, J.T., Kimura, S., Narita, T., Tomita Kamio, Y., Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage φPVL carrying Panton-Valentine leukocidin genes. Gene 215:1 (1998), 57–67.
59. Goerke, C., Pantucek, R., Holtfreter, S., Schulte, B., Zink, M., Grumann, D., Broker, B.M., Doskar, J., Wolz, C., Diversity of prophages in dominant Staphylococcus aureus clonal lineages. J. Bacteriol. 191:11 (2009), 3462–3468.
60. Boakes, E., Kearns, A.M., Ganner, M., Perry, C., Hill, R.L., Ellington, M.J., Distinct bacteriophages encoding Panton-Valentine leukocidin (PVL) among international methicillin-resistant Staphylococcus aureus clones harboring PVL. J. Clin. Microbiol. 49:2 (2011), 684–692.
61. Naimi, T.S., LeDell, K.H., Como-Sabetti, K., Borchardt, S.M., Boxrud, D.J., Etienne, J., Johnson, S.K., Vandenesch, F., Fridkin, S., O'Boyle, C., Danila, R.N., Lynfield, R., Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:22 (2003), 2976–2984.
62. Vandenesch, F., Naimi, T., Enright, M.C., Lina, G., Nimmo, G.R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M.E., Etienne, J., Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9:8 (2003), 978–984.
63. Shukla, S.K., Karow, M.E., Brady, J.M., Stemper, M.E., Kislow, J., Moore, N., Wroblewski, K., Chyou, P.H., Warshauer, D.M., Reed, K.D., Lynfield, R., Schwan, W.R., Virulence genes and genotypic associations in nasal carriage, community-associated methicillin-susceptible and methicillin-resistant USA400 Staphylococcus aureus isolates. J. Clin. Microbiol. 48:10 (2010), 3582–3592.
64. Peacock, S.J., Moore, C.E., Justice, A., Kantzanou, M., Story, L., Mackie, K., O'Neill, G., Day, N.P.J., Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect. Immun. 70:9 (2002), 4987–4996.
65. Shallcross, L.J., Fragaszy, E., Johnson, A.M., Hayward, A.C., The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Inf. Dis. 13:1 (2013), 43–54.
66. Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.O., Gauduchon, V., Vandenesch, F., Etienne, J., Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29:5 (1999), 1128–1132.
67. Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., Etienne, J., Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:9308 (2002), 753–759.
68. Finck-Barbacon, V., Duportail, G., Meunier, O., Colin, D.A., Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochim. Biophys. Acta 1182:1993 (1993), 275–282.
69. Labandeira-Rey, M., Couzon, F., Boisset, S., Brown, E.L., Bes, M., Benito, Y., Barbu, E.M., Vazquez, V., Hook, M., Etienne, J., Vandenesch, F., Bowden, M.G., Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315:5815 (2007), 1130–1133.
70. Brown, E.L., Dumitrescu, O., Thomas, D., Badiou, C., Koers, E.M., Choudhury, P., Vazquez, V., Etienne, J., Lina, G., Vandenesch, F., Bowden, M.G., The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin. Microbiol. Infect. 15:2 (2009), 156–164.
71. Bubeck Wardenburg, J., Palazzolo-Ballance, A.M., Otto, M., Schneewind, O., DeLeo, F.R., Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J. Infect. Dis. 198:8 (2008), 1166–1170.
72. Voyich, J.M., Otto, M., Mathema, B., Braughton, K.R., Whitney, A.R., Welty, D., Long, R.D., Dorward, D.W., Gardner, D.J., Lina, G., Kreiswirth, B.N., DeLeo, F.R., Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?. J. Infect. Dis. 194:12 (2006), 1761–1770.
73. Yoong, P., Pier, G.B., Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infect. Immun. 80:8 (2012), 2894–2904.
74. Spaan, A.N., Henry, T., van Rooijen, W.J.M., Perret, C., Badiou, P.C., Aerts, J., Kemmink, de Haas, C.J., van Kessel, K.P.F., Vandenesch, G., Lina, van Strijp, J.A., The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors. Cell Host Microbe 13:5 (2013), 584–594.
75. Cremieux, A.C., Dumitrescu, O., Lina, G., Vallee, C., Cote, J.F., Muffat-Joly, M., Lilin, T., Etienne, J., Vandenesch, F., Saleh-Mghir, A., Panton-valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One, 4(9), 2009, e7204.
76. Diep, B.A., Chan, L., Tattevin, P., Kajikawa, O., Martin, T.R., Basuino, L., Mai, T.T., Marbach, H., Braughton, K.R., Whitney, A.R., Gardner, D.J., Fan, X., Tseng, C.W., Liu, G.Y., Badiou, C., Etienne, J., Lina, G., Matthay, M.A., DeLeo, F.R., Chambers, H.F., Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc. Natl. Acad. Sci. U. S. A. 107:12 (2010), 5587–5592.
77. Kobayashi, S.D., Malachowa, N., Whitney, A.R., Braughton, K.R., Gardner, D.J., Long, D., Bubeck Wardenburg, J., Schneewind, O., Otto, M., Deleo, F.R., Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J. Infect. Dis. 204:6 (2011), 937–941.
78. Prevost, G., Cribier, B., Couppie, P., Petiau, P., Supersac, G., Finck-Barbacon, V., Monteil, H., Piemont, Y., Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect. Immun., 63(10), 1995.
79. Mollby, R., Wadstrom, T., Separation of gamma hemolysin from Staphylococcus aureus Smith 5R. Infect. Immun. 3:4 (1971), 633–635.
80. Fackrell, H.B., Wiseman, G.M., Production and purification of the gamma haemolysin of Staphylococcus aureus ‘Smith 5R’. J. Gen. Microbiol. 92:1 (1976), 1–10.
81. Fackrell, H.B., Wiseman, G.M., Properties of the gamma haemolysin of Staphylococcus aureus ‘Smith 5R’. J. Gen. Microbiol. 92:1 (1976), 11–24.
82. Supersac, G.G., Prevost Piemont, Y., Sequencing of leucocidin R from Staphylococcus aureus P83 suggests that staphylococcal leucocidins and gamma-hemolysin are members of a single, two-component family of toxins. Infect. Immun. 61:2 (1993), 580–587.
83. Noda, M., Hirayama, T., Kato, I., Matsuda, F., Crystallization and properties of staphylococcal leukocidin. Biochim. Biophys. Acta 633:1 (1980), 33–44.
84. Fueyo, J.M., Mendoza, M.C., Rodicio, M.R., Muniz, J., Alvarez, M.A., Martin, M.C., Cytotoxin and pyrogenic toxin superantigen gene profiles of Staphylococcus aureus associated with subclinical mastitis in dairy cows and relationships with macrorestriction genomic profiles. J. Clin. Microbiol. 43:3 (2005), 1278–1284.
85. Nilsson, I.M., Hartford, O., Foster, T., Tarkowski, A., Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect. Immun. 67:3 (1999), 1045–1049.
86. Morinaga, N.Y., Kaihou Noda, M., Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi-component leukotoxin family. Microbiol. Immunol. 47:1 (2003), 81–90.
87. Alonzo, F. 3rd, Kozhaya, L., Rawlings, S.A., Reyes-Robles, T., DuMont, A.L., Myszka, D.G., Landau, N.R., Unutmaz, D., Torres, V.J., CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 493:7430 (2013), 51–55.
88. Liu, C., Chen, Z.J., Sun, Z., Feng, X., Zou, M., Cao, W., Wang, S., Zeng, J., Wang, Y., Sun, M., Molecular characteristics and virulence factors in methicillin-susceptible, resistant, and heterogeneous vancomycin-intermediate Staphylococcus aureus from central-southern China. J. Microbiol. Immunol. Infect. 48:5 (2015), 490–496.
89. Haveri, M., Roslof, A., Rantala, L., Pyorala, S., Virulence genes of bovine Staphylococcus aureus from persistent and nonpersistent intramammary infections with different clinical characteristics. J. Appl. Microbiol. 103:4 (2007), 993–1000.
90. Dozois, A., Thomsen, I., Jimenez-Truque, N., Soper, N., Pearson, A., Mohamed-Rambaran, P., Dettorre, K.B., Creech, C.B., Wright, S.W., Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus among skin and soft tissue infections in an emergency department in Guyana. Emerg. Med. J. 32:10 (2015), 800–803.
91. Thomsen, I.P., Dumont, A.L., James, D.B., Yoong, P., Saville, B.R., Soper, N., Torres, V.J., Creech, C.B., Children with invasive Staphylococcus aureus disease exhibit a potently neutralizing antibody response to the cytotoxin LukAB. Infect. Immun. 82:3 (2014), 1234–1242.
92. Melehani, J.H., James, D.B., DuMont, A.L., Torres, V.J., Duncan, J.A., Staphylococcus aureus Leukocidin A/B (LukAB) kills human monocytes via host NLRP3 and ASC when extracellular, but not intracellular. PLoS Pathog., 11(6), 2015, e1004970.
93. DuMont, A.L., Yoong, P., Surewaard, B.G., Benson, M.A., Nijland, R., van Strijp, J.A., Torres, V.J., Staphylococcus aureus elaborates leukocidin AB to mediate escape from within human neutrophils. Infect. Immun. 81:5 (2013), 1830–1841.
94. Malachowa, N., Kobayashi, S.D., Braughton, K.R., Whitney, A.R., Parnell, M.J., Gardner, D.J., Deleo, F.R., Staphylococcus aureus leukotoxin GH promotes inflammation. J. Infect. Dis. 206:8 (2012), 1185–1193.
95. Badarau, A.H., Rouha, S., Malafa, D.T., Logan, M., Hakansson, L., Stulik, I., Dolezilkova, A., Teubenbacher, K., Gross, B., Maierhofer, S., Weber, M., Jagerhofer, D., Hoffman Nagy, E., Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH. J. Biol. Chem. 290:1 (2015), 142–156.
96. Rainard, P.J.C., Corrales, M.B., Barrio, T., Cochard Poutrel, B., Leucotoxic activities of Staphylococcus aureus strains isolated from cows, ewes, and goats with mastitis: importance of LukM/LukF’-PV leukotoxin. Clin. Vaccine Immunol. 10:2 (2003), 272–277.
97. Schlotter, K., Ehricht, R., Hotzel, H., Monecke, S., Pfeffer, M., Donat, K., Leukocidin genes lukF-P83 and lukM are associated with Staphylococcus aureus clonal complexes 151, 479 and 133 isolated from bovine udder infections in Thuringia, Germany. Vet. Res., 43, 2012, 42.
98. De Vliegher, S.L.K., Fox, S., Piepers, S., McDougall Barkema, H.W., Invited review: mastitis in dairy heifers: nature of the disease, potential impact, prevention, and control. J. Dairy Sci. 95:3 (2012), 1025–1040.
99. Yamada, T., Tochimaru, N., Nakasuji, S., Hata, E., Kobayashi, H., Eguchi, M., Kaneko, J., Kamio, Y., Kaidoh, T., Takeuchi, S., Leukotoxin family genes in Staphylococcus aureus isolated from domestic animals and prevalence of lukM-lukF-PV genes by bacteriophages in bovine isolates. Vet. Microbiol. 110:1–2 (2005), 97–103.
100. Barrio, M.B., Rainard, P., Prevost, G., LukM/LukF’-PV is the most active Staphylococcus aureus leukotoxin on bovine neutrophils. Microbes Infect. 8:8 (2006), 2068–2074.
101. Freer, J.H.J.P., Arbuthnott Bernheimer, A.W., Interaction of Staphylococcal α-toxin wth artifical and natural membranes. J. Bacteriol. 95:3 (1968), 1153–1168.
102. Watanabe, M.T., Tomita Yasuda, T., Membrane-damaging action of staphylococcal α-toxin on phospholipid cholesterol liposomes. Biochim. Biophys. Acta 898:3 (1987), 257–265.
103. Valeva, A., Hellmann, N., Walev, I., Strand, D., Plate, M., Boukhallouk, F., Brack, A., Hanada, K., Decker, H., Bhakdi, S., Evidence that clustered phosphocholine head groups serve as sites for binding and assembly of an oligomeric protein pore. J. Biol. Chem. 281:36 (2006), 26014–26021.
104. Galdiero, S., Gouaux, E., High resolution crystallographic studies of α-hemolysin-phospholipid complexes define heptamer-lipid head group interactions: implication for understanding protein-lipid interactions. Protein Sci. 13:6 (2004), 1503–1511.
105. Cassidy, P., Six, H.E., Harshman, S., Biological properties of staphylococcal α-toxin. Biochim. Biophys. Acta 332 (1974), 413–423.
106. Maharaj, I., Fackrell, H.B., Rabbit erythrocyte band 3: a receptor for staphylococcal alpha toxin. Can. J. Microbiol. 26:4 (1980), 524–531.
107. 125I-labeled α-toxin to rabbit erythrocytes. Biochemistry 15:11 (1976), 2348–2355.
108. Hildebrand, A.M., Pohl Bhakdi, S., Staphylococcus aureus α-toxin: dual mechanism of binding to target cells. J. Biol. Chem. 266:26 (1991), 17195–17200.
109. Vijayvargia, R.S., Kaur, N., Sangha, A.A., Sahasrabuddhe, I., Surolia, Y., Shouche Krishnasastry, M.V., Assembly of α-hemolysin on A431 cells leads to clustering of Caveolin-1. Biochem. Biophys. Res. Commun. 324:3 (2004), 1124–1129.
110. Pany, S., Krishnasastry, M.V., Aromatic residues of Caveolin-1 binding motif of α-hemolysin are essential for membrane penetration. Biochem. Biophys. Res. Commun. 363:1 (2007), 197–202.
111. Jin, Y., Lee, S.J., Minshall, R.D., Choi, A.M., Caveolin-1: a critical regulator of lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 300:2 (2011), L151–60.
112. Vijayvargia, R., Suresh, C.G., Krishnasastry, M.V., Functional form of Caveolin-1 is necessary for the assembly of α-hemolysin. Biochem. Biophys. Res. Commun. 324:3 (2004), 1130–1136.
113. Wilke, G.A., Bubeck Wardenburg, J., Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin-mediated cellular injury. Proc. Natl. Acad. Sci. U. S. A. 107:30 (2010), 13473–13478.
114. Popov, L.M., Marceau, C.D., Starkl, P.M., Lumb, J.H., Shah, J., Guerrera, D., Cooper, R.L., Merakou, C., Bouley, D.M., Meng, W., Kiyonari, H., Takeichi, M., Galli, S.J., Bagnoli, F., Citi, S., Carette, J.E., Amieva, M.R., The adherens junctions control susceptibility to Staphylococcus aureus α-toxin. Proc. Natl. Acad. Sci. U. S. A. 112:46 (2015), 14337–14342.
115. Virreira Winter, S., Zychlinsky, A., Bardoel, B.W., Genome-wide CRISPR screen reveals novel host factors required for Staphylococcus aureus α-hemolysin-mediated toxicity. Sci. Rep., 6, 2016, 24242.
116. von Hoven, G.A.J., Riva, C., Neukirch, S., Klei, C., Ham, Q., Qi, M., Meyenburg, S., Fuser, P., Saftig, N., Hellmann, R., Postina Husmann, M., Dissecting the role of ADAM10 as a mediator of S. aureus α-toxin action. Biochem. J. 473:13 (2016), 1929–1940.
117. Weber, S., Niessen, M.T., Prox, J., Lullmann-Rauch, R., Schmitz, A., Schwanbeck, R., Blobel, C.P., Jorissen, E., de Strooper, B., Niessen, C.M., Saftig, P., The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling. Development 138:3 (2011), 495–505.
118. Alabi, R.O., Glomski, K., Haxaire, C., Weskamp, G., Monette, S., Blobel, C.P., ADAM10-dependent signaling through Notch1 and Notch4 controls development of organ-specific vascular beds. Circ. Res. 119:4 (2016), 519–531.
119. Hattori, M., Osterfield, M., Flanagan, J.G., Regulated cleavage of a contact-mediated axon repellent. Science 289:5483 (2000), 1360–1365.
120. Pan, D., Rubin, G.M., Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90:2 (1997), 271–280.
121. Maretzky, T., Reiss, K., Ludwig, A., Buchholz, J., Scholz, F., Proksch, E., de Strooper, B., Hartmann, D., Saftig, P., ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and β-catenin translocation. Proc. Natl. Acad. Sci. U. S. A. 102:26 (2005), 9182–9187.
122. Lemjabbar, H., Basbaum, C., Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat. Med. 8:1 (2002), 41–46.
123. Schulz, B., Pruessmeyer, J., Maretzky, T., Ludwig, A., Blobel, C.P., Saftig, P., Reiss, K., ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ. Res. 102:10 (2008), 1192–1201.
124. Colciaghi, F.B., Borroni, L., Pastorino, E., Marcello, M., Zimmerman, F., Cattabeni, Padovani, A., Di Luca, M., α-Secretase ADAM10 as well as αAPPs is reduced in platelets and CSF of Alzheimer disease patients. Mol. Med. 8:2 (2002), 67–74.
125. Jouannet, S., Saint-Pol, J., Fernandez, L., Nguyen, V., Charrin, S., Boucheix, C., Brou, C., Milhiet, P.E., Rubinstein, E., TspanC8 tetraspanins differentially regulate the cleavage of ADAM10 substrates, Notch activation and ADAM10 membrane compartmentalization. Cell. Mol. Life Sci. 73:9 (2016), 1895–1915.
126. Noy, P.J., Yang, J., Reyat, J.S., Matthews, A.L., Charlton, A.E., Furmston, J., Rogers, D.A., Rainger, G.E., Tomlinson, M.G., TspanC8 tetraspanins and a disintegrin and metalloprotease 10 (ADAM10) interact via their extracellular regions: evidence for distinct binding mechanisms for different TspanC8 proteins. J. Biol. Chem. 291:7 (2016), 3145–3157.
127. Karginov, V.A.E.M., Nestorovich, F., Schmidtmann, T.M., Robinson, A., Yohannes, N.E., Fahmi, S.M., Bezrukov Hecht, S.M., Inhibition of S. aureus α-hemolysin and B. anthracis lethal toxin by β-cyclodextrin derivatives. Bioorg. Med. Chem. 15:16 (2007), 5424–5431.
128. Yannakopoulou, K.L., Jicsinszky, C., Aggelidou, N., Mourtzis, T.M., Robinson, A., Yohannes, E.M., Nestorovich, S.M., Bezrukov Karginov, V.A., Symmetry requirements for effective blocking of pore-forming toxins: comparative study with α-, β-, and γ-cyclodextrin derivatives. Antimicrob. Agents Chemother. 55:7 (2011), 3594–3597.
129. Reiss, K.T., Maretzky, A., Ludwig, Tousseyn, T., de Strooper, B.D., Hartmann, P., Saftig, ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and β-catenin nuclear signalling. EMBO J. 24:4 (2005), 742–752.
130. Sanderson, M.P., Erickson, S.N., Gough, P.J., Garton, K.J., Wille, P.T., Raines, E.W., Dunbar, A.J., Dempsey, P.J., ADAM10 mediates ectodomain shedding of the betacellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx. J. Biol. Chem. 280:3 (2005), 1826–1837.
131. Los, F.C., Randis, T.M., Aroian, R.V., Ratner, A.J., Role of pore-forming toxins in bacterial infectious diseases. Microbiol. Mol. Biol. Rev. 77:2 (2013), 173–207.
132. Alkhatib, G.C., Combadiere, C.C., Broder, Y., Feng, P.E., Kennedy, P.M., Murphy, E.A., Berger, CC. CKR5: a RANTES, MIP-1α MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:5270 (1996), 1955–1958.
133. Choe, H., Moore, M.J., Owens, C.M., Wright, P.L., Vasilieva, N., Li, W., Singh, A.P., Shakri, R., Chitnis, C.E., Farzan, M., Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC). Mol. Microbiol. 55:5 (2005), 1413–1422.
134. Choe, H., Li, W., Wright, P.L., Vasilieva, N., Venturi, M., Huang, C.C., Grundner, C., Dorfman, T., Zwick, M.B., Wang, L., Rosenberg, E.S., Kwong, P.D., Burton, D.R., Robinson, J.E., Sodroski, J.G., Farzan, M., Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell 114:2 (2003), 161–170.
135. Tan, J.H., Ludeman, J.P., Wedderburn, J., Canals, M., Hall, P., Butler, S.J., Taleski, D., Christopoulos, A., Hickey, M.J., Payne, R.J., Stone, M.J., Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1). J. Biol. Chem. 288:14 (2013), 10024–10034.
136. Ludeman, J.P., Stone, M.J., The structural role of receptor tyrosine sulfation in chemokine recognition. Br. J. Pharmacol. 171:5 (2014), 1167–1179.
137. Iwamoto, S., Omi, T., Kajii, E., Ikemoto, S., Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 85:3 (1995), 622–626.
138. Tournamille, C., Colin, Y., Cartron, J.P., Le Van Kim, C., Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10:2 (1995), 224–228.
139. Zimmerman, P.A., Woolley, I., Masinde, G.L., Miller, S.M., McNamara, D.T., Hazlett, F., Mgone, C.S., Alpers, M.P., Genton, B., Boatin, B.A., Kazura, J.W., Emergence of FY*Anull in a Plasmodium vivax-endemic region of Papua New Guinea. Proc. Natl. Acad. Sci. U. S. A. 96:24 (1999), 13973–13977.
140. Tournamille, C., Le Van Kim, C.P., Gane, Le Pennec, P.Y.F., Roubinet, J., Babinet, J.P., Carton, Y., Colin, Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fyx individuals. Blood 92:6 (1998), 2147–2156.
141. Wan, W., Liu, Q., Lionakis, M.S., Marino, A.P., Anderson, S.A., Swamydas, M., Murphy, P.M., Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice. Cardiovasc. Res. 106:3 (2015), 478–487.
142. de Haas, C.J., Veldkamp, K.E., Peschel, A., Weerkamp, F., Van Wamel, W.J., Heezius, E.C., Poppelier, M.J., Van Kessel, K.P., van Strijp, J.A., Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J. Exp. Med. 199:5 (2004), 687–695.
143. Thammavongsa, V., Kim, H.K., Missiakas, D., Schneewind, O., Staphylococcal manipulation of host immune responses. Nat. Rev. Microbiol. 13:9 (2015), 529–543.
144. Grojec, P., Jeljaszewicz, J., Effect of staphylococcal leukocidin on mouse leukocyte system. Zentralbl. Bakteriol. Mikrobiol. Hyg. 250 (1981), 446–455.
145. Knop, J., Hanses, F., Leist, T., Archin, N.M., Buchholz, S., Glasner, J., Gessner, A., Wege, A.K., Staphylococcus aureus infection in humanized mice: a new model to study pathogenicity associated with human immune response. J. Infect. Dis. 212:3 (2015), 435–444.
146. Prince, A., Wang, H., Kitur, K., Parker, D., Humanized mice exhibit increased susceptibility to Staphylococcus aureus pneumonia. J. Infect. Dis., 2016, 10.1093/infdis/jiw425.
147. Tseng, C.W., Biancotti, J.C., Berg, B.L., Gate, D., Kolar, S.L., Muller, S., Rodriguez, M.D., Rezai-Zadeh, K., Fan, X., Beenhouwer, D.O., Town, T., Liu, G.Y., Increased susceptibility of humanized NSG mice to Panton-Valentine leukocidin and Staphylococcus aureus skin infection. PLoS Pathog., 11(11), 2015, e1005292.
148. Gauduchon, V., Werner, S., Prevost, G., Monteil, H., Colin, D.A., Flow cytometric determination of Panton-Valentine leucocidin S component binding. Infect. Immun. 69:4 (2001), 2390–2395.
149. Suttorp, N., Seeger, W., Dewein, E., Bhakdi, S., Roka, L., Staphylococcal α-toxin-induced PGI2 production in endothelial cells: role of calcium. Am. J. Physiol. 248:1 (Pt. 1) (1985), C127–C134.
150. 2+ mobilization by human neutrophils. Cell. Microbiol. 17:8 (2015), 1241–1257.
151. Jonas, D., Walev, I., Berger, T., Liebetrau, M., Palmer, M., Bhakdi, S., Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect. Immun. 62:4 (1994), 1304–1312.
152. Noda, M., Kato, I., Hirayama, T., Matsuda, F., Mode of action of staphylococcal leukocidin: effects of the S and F components on the activities of membrane-associated enzymes of rabbit polymorphonuclear leukocytes. Infect. Immun. 35:1 (1982), 38–45.
153. Eiffler, I., Behnke, J., Ziesemer, S., Muller, C., Hildebrandt, J.P., Staphylococcus aureus α-toxin-mediated cation entry depolarizes membrane potential and activates p38 MAP kinase in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 311:3 (2016), L676–685.
154. Below, S., Konkel, A., Zeeck, C., Muller, C., Kohler, C., Engelmann, S., Hildebrandt, J.P., Virulence factors of Staphylococcus aureus induce Erk-MAP kinase activation and c-Fos expression in S9 and 16HBE14o- human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 296:3 (2009), L470–9.
155. Flannagan, R.S., Cosio, G., Grinstein, S., Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat. Rev. Microbiol. 7:5 (2009), 355–366.
156. Bonazzi, M., Lecuit, M., Cossart, P., Listeria monocytogenes internalin and E-cadherin: from bench to bedside. Cold Spring Harb. Perspect. Biol., 1(4), 2009, a003087.
157. Ke, Y., Chen, Z., Yang, R., Yersina pestis: mechanisms of entry into and resistance to the host cell. Front. Cell. Infect. Microbiol., 3, 2013, 106.
158. Castleman, M.J., Febbraio, M., Hall, P.R., CD36 is essential for regulation of the host innate response to Staphylococcus aureus α-toxin-mediated dermonecrosis. J. Immunol. 195:5 (2015), 2294–2302.
159. Kitur, K., Wachtel, S., Brown, A., Wickersham, M., Paulino, F., Penaloza, H.F., Soong, G., Bueno, S., Parker, D., Prince, A., Necroptosis promotes Staphylococcus aureus clearance by inhibiting excessive inflammatory signaling. Cell Rep. 16:8 (2016), 2219–2230.
160. Miller, L.S., O'Connell, R.M., Gutierrez, M.A., Pietras, E.M., Shahangian, A., Gross, C.E., Thirumala, A., Cheung, A.L., Cheng, G., Modlin, R.L., MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 24:1 (2006), 79–91.
161. Bhakdi, S.M., Muhly, S., Korom Hugo, F., Release of interleukin-1β associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect. Immun. 57:11 (1989), 3512–3519.
162. Holzinger, D., Gieldon, L., Mysore, V., Nippe, N., Taxman, D.J., Duncan, J.A., Broglie, P.M., Marketon, K., Austermann, J., Vogl, T., Foell, D., Niemann, S., Peters, G., Roth, J., Loffler, B., Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome. J. Leukoc. Biol. 92:5 (2012), 1069–1081.
163. Craven, R.R., Gao, X., Allen, I.C., Gris, D., Bubeck Wardenburg, J., McElvania-Tekippe, E., Ting, J.P., Duncan, J.A., Staphylococcus aureus α-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One, 4(10), 2009, e7446.
164. Netea, M.G., Simon, A., van de Veerdonk, F., Kullberg, B.J., Van der Meer, J.W., Joosten, L.A., IL-1β processing in host defense: beyond the inflammasomes. PLoS Pathog., 6(2), 2010, e1000661.
165. Becker, R.E., Berube, B.J., Sampedro, G.R., DeDent, A.C., J Bubeck Wardenburg, Tissue-specific patterning of host innate immune responses by Staphylococcus aureus α-toxin. J. Innate Immun. 6:5 (2014), 619–631.
166. Kebaier, C.R.R., Chamberland, I.C., Allen, X., Gao, P.M., Broglie, J.D., Hall, C., Jania, C.M., Doerschuk, S.L., Tilley Duncan, J.A., Staphylococcus aureus α-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. J. Infect. Dis. 205:5 (2012), 807–817.
167. Cho, J.S., Guo, Y., Ramos, R.I., Hebroni, F., Plaisier, S.B., Xuan, C., Granick, J.L., Matsushima, H., Takashima, A., Iwakura, Y., Cheung, A.L., Cheng, G., Lee, D.J., Simon, S.I., Miller, L.S., Neutrophil-derived IL-1β is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog., 8(11), 2012, e1003047.
168. Hensler, T., Koller, M., Prevost, G., Piemont, Y., Konig, W., GTP-binding proteins are involved in the modulated activity of human neutrophils treated with the Panton-Valentine leukocidin from Staphylococcus aureus. Infect. Immun. 62:12 (1994), 5281–5289.
169. Graves, S.F., Kobayashi, S.D., Braughton, K.R., Whitney, A.R., Sturdevant, D.E., Rasmussen, D.L., Kirpotina, L.N., Quinn, M.T., DeLeo, F.R., Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity. J. Leukoc. Biol. 92:2 (2012), 361–374.
170. Colin, D.A., Monteil, H., Control of the oxidative burst of human neutrophils by staphylococcal leukotoxins. Infect. Immun. 71:7 (2003), 3724–3729.
171. Yoong, P., Pier, G.B., Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proc. Natl. Acad. Sci. U. S. A. 107:5 (2010), 2241–2246.
172. Bleriot, C., Lecuit, M., The interplay between regulated necrosis and bacterial infection. Cell. Mol. Life Sci. 73:11–12 (2016), 2369–2378.
173. Vince, J.E., Silke, J., The intersection of cell death and inflammasome activation. Cell. Mol. Life Sci. 73:11–12 (2016), 2349–2367.
174. Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., Kroemer, G., Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11:10 (2010), 700–714.
175. Kitur, K., Parker, D., Nieto, P., Ahn, D.S., Cohen, T.S., Chung, S., Wachtel, S., Bueno, S., Prince, A., Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage. PLoS Pathog., 11(4), 2015, e1004820.
176. Gonzalez-Juarbe, N., Gilley, R.P., Hinojosa, C.A., Bradley, K.M., Kamei, A., Gao, G., Dube, P.H., Bergman, M.A., Orihuela, C.J., Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia. PLoS Pathog., 11(12), 2015, e1005337.
177. Jarry, T.M., Memmi, G., Cheung, A.L., The expression of alpha-haemolysin is required for Staphylococcus aureus phagosomal escape after internalization in CFT-1 cells. Cell. Microbiol. 10:9 (2008), 1801–1814.
178. Cohen, T.S., Hilliard, J.J., Jones-Nelson, O., Keller, A.E., O'Day, T., Tkaczyk, C., DiGiandomenico, A., Hamilton, M., Pelletier, M., Wang, Q., Diep, B.A., Le, V.T., Cheng, L., Suzich, J., Stover, C.K., Sellman, B.R., Staphylococcus aureus α toxin potentiates opportunistic bacterial lung infections. Sci. Transl. Med., 8(329), 2016, 329ra31.
179. Chi, C.Y., Lin, C.C., Liao, I.C., Yao, Y.C., Shen, F.C., Liu, C.C., Lin, C.F., Panton-Valentine leukocidin facilitates the escape of Staphylococcus aureus from human keratinocyte endosomes and induces apoptosis. J. Infect. Dis. 209:2 (2014), 224–235.
180. Munzenmayer, L., Geiger, T., Daiber, E., Schulte, B., Autenrieth, S.E., Fraunholz, M., Wolz, C., Influence of Sae-regulated and Agr-regulated factors on the escape of Staphylococcus aureus from human macrophages. Cell. Microbiol. 18:8 (2016), 1172–1183.
181. Malachowa, N., Kobayashi, S.D., Freedman, B., Dorward, D.W., DeLeo, F.R., Staphylococcus aureus leukotoxin GH promotes formation of neutrophil extracellular traps. J. Immunol. 191:12 (2013), 6022–6029.
182. Birmingham, C.L., Canadien, V., Kaniuk, N.A., Steinberg, B.E., Higgins, D.E., Brumell, J.H., Listeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles. Nature 451:7176 (2008), 350–354.
183. Surewaard, B.G., Deniset, J.F., Zemp, F.J., Amrein, M., Otto, M., Conly, J., Omri, A., Yates, R.M., Kubes, P., Identification and treatment of the Staphylococcus aureus reservoir in vivo. J. Exp. Med. 213:7 (2016), 1141–1151.
184. Abel, J., Goldmann, O., Ziegler, C., Holtje, C., Smeltzer, M.S., Cheung, A.L., Bruhn, D., Rohde, M., Medina, E., Staphylococcus aureus evades the extracellular antimicrobial activity of mast cells by promoting its own uptake. J. Innate Immun. 3:5 (2011), 495–507.
185. Goldmann, O.L., Tuchscherr, M., Rohde Medina, E., -Hemolysin enhances Staphylococcus aureus internalization and survival within mast cells by modulating the expression of (1 integrin. Cell. Microbiol. 18:6 (2016), 807–819.
186. Ernst, J.D., Macrophage receptors for Mycobacterium tuberculosis. Infect. Immun. 66:4 (1998), 1277–1281.
187. Wang, M.M.A.K., Shakhatreh, D., James, S., Liang, Si Nishiyama, F., Yoshimura, D.R., Demuth, Hajishengallis, G., Fimbrial proteins of Porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and Complement Receptor 3 to persist in macrophages. J. Immunol. 179:4 (2007), 2349–2358.
188. Kwak, Y.K.E., Vikstrom, K.E., Magnusson, Vecsey-Semjen, B., Colque-Navarro, P.R., Mollby, The, Staphylococcus aureus alpha-toxin perturbs the barrier function in Caco-2 epithelial cell monolayers by altering junctional integrity. Infect. Immun. 80:5 (2012), 1670–1680.
189. Mairpady Shambat, S., Chen, P., Nguyen Hoang, A.T., Bergsten, H., Vandenesch, F., Siemens, N., Lina, G., Monk, I.R., Foster, T.J., Arakere, G., Svensson, M., Norrby-Teglund, A., Modelling staphylococcal pneumonia in a human 3D lung tissue model system delineates toxin-mediated pathology. Dis. Model. Mech. 8:11 (2015), 1413–1425.
190. Bronner, S., Stoessel, P., Gravet, A., Monteil, H., Prevost, G., Variable expressions of Staphylococcus aureus bicomponent leucotoxins semiquantified by competitive reverse transcription-PCR. Appl. Environ. Microbiol. 66:9 (2000), 3931–3938.
191. Dunman, P.M., Murphy, E., Haney, S., Palacios, D., Tucker-Kellogg, G., Wu, S., Brown, E.L., Zagursky, R.J., Shlaes, D., Projan, S.J., Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J. Bacteriol. 183:24 (2001), 7341–7353.
192. Loughman, J.A., Fritz, S.A., Storch, G.A., Hunstad, D.A., Virulence gene expression in human community-acquired Staphylococcus aureus infection. J. Infect. Dis. 199:3 (2009), 294–301.
193. Malachowa, N., Whitney, A.R., Kobayashi, S.D., Sturdevant, D.E., Kennedy, A.D., Braughton, K.R., Shabb, D.W., Diep, B.A., Chambers, H.F., Otto, M., DeLeo, F.R., Global changes in Staphylococcus aureus gene expression in human blood. PLoS One, 6(4), 2011, e18617.
194. Balasubramanian, D., Ohneck, E.A., Chapman, J., Weiss, A., Kim, M.K., Reyes-Robles, T., Zhong, J., Shaw, L.N., Lun, D.S., Ueberheide, B., Shopsin, B., Torres, V.J., Staphylococcus aureus coordinates leukocidin expression and pathogenesis by sensing metabolic fluxes via RpiRc. MBio, 7(3), 2016.
195. Parimon, T., Li, Z., Bolz, D.D., McIndoo, E.R., Bayer, C.R., Stevens, D.L., Bryant, A.E., Staphylococcus aureus α-hemolysin promotes platelet-neutrophil aggregate formation. J. Infect. Dis. 208:5 (2013), 761–770.
196. Perret, M., Badiou, C., Lina, G., Burbaud, S., Benito, Y., Bes, M., Cottin, V., Couzon, F., Juruj, C., Dauwalder, O., Goutagny, N., Diep, B.A., Vandenesch, F., Henry, T., Cross-talk between Staphylococcus aureus leukocidins-intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent manner. Cell. Microbiol. 14:7 (2012), 1019–1036.
197. Glomski, K., Monette, S., Manova, K., De Strooper, B., Saftig, P., Blobel, C.P., Deletion of Adam10 in endothelial cells leads to defects in organ-specific vascular structures. Blood 118:4 (2011), 1163–1174.
198. Hartmann, D., de Strooper, B., Serneels, L., Craessaerts, K., Herreman, A., Annaert, W., Umans, L., Lubke, T., Lena Illert, A., von Figura, K., Saftig, P., The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for α-secretase activity in fibroblasts. Hum. Mol. Gen. 11:21 (2002), 2615–2624.
199. Cremieux, A.C., Saleh-Mghir, A.C., Danel, F., Couzon, O., Dumitrescu, T., Lilin, C., Perronne, J., Etienne, G., Lina, Vandenesch, F., α-Hemolysin, not Panton-Valentine leukocidin, impacts rabbit mortality from severe sepsis with methicillin-resistant Staphylococcus aureus osteomyelitis. J. Infect. Dis. 209:11 (2014), 1773–1780.
200. Bermejo-Martin, J.F., Andaluz-Ojeda, D., Almansa, R., Gandia, F., Gomez-Herreras, J.I., Gomez-Sanchez, E., Heredia-Rodriguez, M., Eiros, J.M., Kelvin, D.J., Tamayo, E., Defining immunological dysfunction in sepsis: a requisite tool for precision medicine. J. Infect. 72:5 (2016), 525–536.
201. Powers, M.E., Becker, R.E., Sailer, A., Turner, J.R., Bubeck Wardenburg, J., Synergistic action of Staphylococcus aureus alpha-toxin on platelets and myeloid lineage cells contributes to lethal sepsis. Cell Host Microbe 17:6 (2015), 775–787.
202. Patzelt, J., Mueller, K.A., Breuning, S., Karathanos, A., Schleicher, R., Seizer, P., Gawaz, M., Langer, H.F., Geisler, T., Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease. Atherosclerosis 238:2 (2015), 289–295.
203. Ragle, B.E., Bubeck Wardenburg, J., Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect. Immun. 77:7 (2009), 2712–2718.
204. Ragle, B.E., Karginov, V.A., Bubeck Wardenburg, J., Prevention and treatment of Staphylococcus aureus pneumonia with a β-cyclodextrin derivative. Antimicrob. Agents Chemother. 54:1 (2010), 298–304.
205. Diep, B.A., Le, V.T., Visram, Z.C., Rouha, H., Stulik, L., Dip, E.C., Nagy, G., Nagy, E., Improved protection in a rabbit model of community-associated methicillin-resistant Staphylococcus aureus necrotizing pneumonia upon neutralization of leukocidins in addition to α-hemolysin. Antimicrob. Agents Chemother. 60:10 (2016), 6333–6340.
206. Rouha, H.A., Badarau, Z.C., Visram, M.B., Battles, B., Prinz, Z., Magyarics, G., Nagy, I., Mirkina, L., Stulik, M., Zerbs, M., Jagerhofer, B., Maierhofer, A., Teubenbacher, I., Dolezilkova, K., Gross, S., Banerjee, G., Zauner, S., Malafa, J., Zmajkovic, S., Maier, R., Mabry, E., Krauland, K.D., Wittrup, T.U., Gerngross Nagy, E., Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody. MAbs 7:1 (2015), 243–254.
207. Laventie, B.J.C., Potrich, C., Atmanene, M., Saleh, O., Joubert, G., Viero, C., Bachmeyer, V., Antonini, I., Mancini, Cianferani-Sanglier, S.D., Keller, D.A., Colin, T., Bourcier, Anderluh, G., van Dorsselaer, A., Dalla Serra, M., Prevost, G., p-Sulfonato-calix[n]arenes inhibit staphylococcal bicomponent leukotoxins by supramolecular interactions. Biochem. J. 450:3 (2013), 559–571.
208. Badarau, A., Rouha, H., Malafa, S., Battles, M.B., Walker, L., Nielson, N., Dolezilkova, I., Teubenbacher, A., Banerjee, S., Maierhofer, B., Weber, S., Stulik, L., Logan, D.T., Welin, M., Mirkina, I., Pleban, C., Zauner, G., Gross, K., Jagerhofer, M., Magyarics, Z., Nagy, E., Context matters: the importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies. MAbs 8:7 (2016), 1347–1360.
209. Lee, H., Zahra, D., Vogelzang, A., Newton, R., Thatcher, J., Quan, A., So, T., Zwirner, J., Koentgen, F., Padkjaer, S.B., Mackay, F., Whitfeld, P.L., Mackay, C.R., Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies. Nat. Biotechnol. 24:10 (2006), 1279–1284.